Related Experiment Videos
Antigenic sites on mouse 2.5S nerve growth factor
Molecular Immunology
|February 1, 1982
Summary
Researchers investigated Nerve Growth Factor (NGF) peptides to understand their role in antibody binding. A specific tryptic peptide, G7, showed significant inhibitory activity, suggesting it contains key binding epitopes for anti-NGF antibodies.
Area of Science:
- Neuroscience
- Immunology
- Protein Chemistry
Background:
- Nerve Growth Factor (NGF) is crucial for neuronal development and survival.
- Understanding NGF's structure-function relationship is key to its therapeutic applications.
- Antibodies against NGF can neutralize its biological activity.
Purpose of the Study:
- To identify specific regions of NGF responsible for antibody binding.
- To characterize the inhibitory potential of NGF-derived peptides in antibody binding assays.
- To explore structure-activity relationships of NGF epitopes recognized by anti-NGF antibodies.
Main Methods:
- Competitive inhibition assays using cyanogen bromide and tryptic peptides of mouse NGF.
- Solid-phase radioimmunoassay to measure binding of rabbit antiserum anti-NGF to native NGF.
- Purification and characterization of ten tryptic peptides from a larger cyanogen bromide fragment.
Main Results:
- The larger cyanogen bromide fragment (residues 10-118) showed significant competitive inhibition, similar to native NGF.
- Tryptic peptide G7 (residues 58-59, 60-69, 104-114) demonstrated potent inhibitory activity, albeit at higher concentrations.
- Peptide G7 and G10-H1 exhibited a synergistic inhibitory effect when used together, unlike other peptide combinations.
Conclusions:
- Peptide G7 contains critical epitopes for anti-NGF antibody binding, contributing significantly to NGF's antigenicity.
- The N-terminal peptide (residues 1-9) and other tryptic peptides, including DE-5, lack significant antibody-binding epitopes.
- Synergistic effects between specific NGF peptides highlight complex epitope interactions relevant for antibody recognition.